143 related articles for article (PubMed ID: 15099473)
1. [Features of micro satellite alterations on chromosome 4 in hepatocellular carcinoma].
Zhang SH; Cong WM; Xian ZH; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):223-6. PubMed ID: 15099473
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between microsatellite alterations on chromosome 8 and clinicopathological characteristics in hepatocellular carcinoma].
Zhang SH; Cong WM; Xian ZH; Wu MC
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):429-32. PubMed ID: 15498212
[TBL] [Abstract][Full Text] [Related]
3. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
4. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
5. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
Li X; Ding M; Lai B
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
[TBL] [Abstract][Full Text] [Related]
6. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
7. [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
Pang JZ; Qin LX; Wang QQ; Ren N; Sun BS; Lin GL; Ye QH; Liu YK; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):906-9. PubMed ID: 18171524
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
9. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
10. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
Piao Z; Kim H; Jeon BK; Lee WJ; Park C
Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
[TBL] [Abstract][Full Text] [Related]
11. Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.
Dore MP; Realdi G; Mura D; Onida A; Massarelli G; Dettori G; Graham DY; Sepulveda AR
Hum Pathol; 2001 Jul; 32(7):698-703. PubMed ID: 11486168
[TBL] [Abstract][Full Text] [Related]
12. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
14. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
15. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
Zhao X; Wan D; Jiang H
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
[TBL] [Abstract][Full Text] [Related]
16. Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma.
Hammond C; Jeffers L; Carr BI; Simon D
Hepatology; 1999 May; 29(5):1479-85. PubMed ID: 10216132
[TBL] [Abstract][Full Text] [Related]
17. Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma.
Lu T; Hano H
Liver Int; 2007 Aug; 27(6):782-90. PubMed ID: 17617121
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
19. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]